Ipsen to acquire Epizyme, expanding its portfolio in oncology
Ipsen and Epizyme declared today that they have signed a legally binding merger agreement that would see Ipsen acquire Epizyme. The boards of directors of both Ipsen and Epizyme unanimously authorised the deal, and it is anticipated that it will…